According to Cboe's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 29.3121. At the end of 2022 the company had a P/E ratio of 57.3.
Year | P/E ratio | Change |
---|---|---|
2022 | 57.3 | 116.6% |
2021 | 26.5 | 21.57% |
2020 | 21.8 | -38.9% |
2019 | 35.6 | 37.22% |
2018 | 25.9 | -25.85% |
2017 | 35.0 | 7.52% |
2016 | 32.6 | 23.38% |
2015 | 26.4 | -8.07% |
2014 | 28.7 | 9.91% |
2013 | 26.1 | 57.76% |
2012 | 16.6 | -2.72% |
2011 | 17.0 | -22.6% |
2010 | 22.0 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
CME Group CME | 25.3 | -13.56% | ๐บ๐ธ USA |
Intercontinental Exchange ICE | 30.7 | 4.69% | ๐บ๐ธ USA |
Nasdaq NDAQ | 27.3 | -6.75% | ๐บ๐ธ USA |
BGC Group
BGC | 202 | 589.14% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.